English to Italian Medical Medical: Pharmaceuticals

Subjects will be further followed on the study days:
• 2, 3 and 5 (assessments: Haematology, Biochemistry, Fibrinogen for PK, Recording of AEs, including potential thromboembolic events)
• 7 (assessments: Fibrinogen for PK, Recording of AEs, including potential thromboembolic events)
• 10 (assessments: Virus Safety, Retain sample, Fibrinogen for PK, Recording of AEs, including potential thromboembolic events)
• 14 (assessments: Vital signs, Physical examination, Haematology, Biochemistry, Fibrinogen for PK, Final clinical evaluation of any signs or symptoms of potential thromboembolic events, Recording of AEs.)
• 45-day period on final day (assessments: Virus safety (anti-HIV-1/-2, anti-HAV and PCR analysis for HAV, HBV, HCV, and HIV-1), Retain sample, Recording of AEs.).